Mott to host live Q & A on COVID vaccines and kids

University of Michigan Health C.S. Mott Children’s Hospital leader to moderate live discussion with three pediatric doctors on Friday, Sept.17.

Author | Beata Mostafavi

Parents with children who are 12 and older – or whose child will soon be 12 – may still be deciding whether to vaccinate them against COVID.

And those with younger children may be looking to learn more about the vaccine with the news that a dose may soon be authorized for children ages 5-11 and as the delta variant continues to disrupt school for many kids across the country.

Families will have a chance to ask three pediatric experts from University of Michigan Health C.S. Mott Children’s Hospital their top questions about COVID vaccination for kids during a live Q & A session at 11 a.m. Friday, Sept. 17.

Luanne Thomas Ewald, FACHE, M.H.A., chief operating officer at Mott and Von Voigtlander Women’s Hospital will moderate the event. Panelists will include pediatric infectious diseases expert Elizabeth Lloyd, M.D.; pediatrician

Alanna Nzoma, M.D.; and pediatric pulmonologist Ixsy Ramirez, M.D. who sees kids in the pediatric post-COVID syndrome clinic at Mott)

“We understand that there are different concerns when it comes to getting the COVID-19 vaccine, especially when parents are making this decision for their child,” Ewald said.

“We hope to offer an opportunity to help families learn more in order to make an informed choice.”

The live discussion will be held on both the @MottChildren and @MichiganMedicine Facebook pages as well as the @UMichMedicine and @MottChildren Twitter accounts and the Michigan Medicine YouTube channel. 

Attendees may ask questions live at the time of the event. The video of the chat will also be available on these platforms for those who would like to view it afterwards.

Topics include:

  • What to expect after getting the vaccine
  • Side effects of the vaccine
  • Weighing risks
  • Fertility questions
  • Concerns about myocarditis
  • Vaccine approval process and the difference between the vaccine for those over and under the age of 12
  • COVID antibodies and getting the vaccine
  • Herd immunity
  • Who shouldn’t get the vaccine
  • COVID risks to kids during the delta wave
Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories girl sitting on couch with brace on and standing with brace on in UM shirts
Health Lab
Live donor cartilage allows musician to return to the stage
A musician receives live donor cartilage that changes her life.
doctor in white coat with dark blue scrubs touching hand of patient in grey sweater and baseball cap in exam room
Health Lab
Neuropathy common, and mostly undiagnosed, among patients in this Michigan city
A research team, led by Michigan Medicine and in partnership with Hurley Medical Center, finds that nearly three-quarters of patients at a clinic in Flint, Mich., a community that is predominantly Black and socioeconomically disadvantaged, had neuropathy — of which 75% was undiagnosed.
cancer cell blue yellow
Health Lab
Widening inequality seen where cancer clinical trials are available
The availability of clinical trials of new treatments for cancer varies greatly by geography, and a new study shows more socially vulnerable areas have far fewer.
man in black polo folded arms smiling no teeth bright orange background
Health Lab
Comedy and medicine
An ophthalmologist and beloved comedian shares his thoughts on the field to aspiring clinicians.
man smiling with cupcakes glasses
Health Lab
Two heart transplants, one message for organ donation
A patient who has received two heart transplants years apart shares his story and the importance of advocating for organ donation.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.